PMC:7029759 / 36257-36386 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"951","span":{"begin":43,"end":47},"obj":"Gene"},{"id":"955","span":{"begin":15,"end":24},"obj":"Species"},{"id":"959","span":{"begin":119,"end":128},"obj":"Disease"}],"attributes":[{"id":"A951","pred":"tao:has_database_id","subj":"951","obj":"Gene:59272"},{"id":"A955","pred":"tao:has_database_id","subj":"955","obj":"Tax:2697049"},{"id":"A959","pred":"tao:has_database_id","subj":"959","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"By comparison, 2019-nCoV cannot escape the ACE2-Fc treatment strategy, since it leverages its own cognate receptor for infection."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T670","span":{"begin":15,"end":24},"obj":"SP_7"},{"id":"T669","span":{"begin":43,"end":47},"obj":"G_3;PG_10;PR:000003622"}],"text":"By comparison, 2019-nCoV cannot escape the ACE2-Fc treatment strategy, since it leverages its own cognate receptor for infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T123","span":{"begin":119,"end":128},"obj":"Disease"}],"attributes":[{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"By comparison, 2019-nCoV cannot escape the ACE2-Fc treatment strategy, since it leverages its own cognate receptor for infection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T374","span":{"begin":48,"end":50},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"By comparison, 2019-nCoV cannot escape the ACE2-Fc treatment strategy, since it leverages its own cognate receptor for infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T225","span":{"begin":0,"end":129},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"By comparison, 2019-nCoV cannot escape the ACE2-Fc treatment strategy, since it leverages its own cognate receptor for infection."}